Consensus Corebridge Financial, Inc.

Equities

CRBG

US21871X1090

Life & Health Insurance

Real-time Estimate Cboe BZX Other stock markets 08:40:25 15/01/2026 pm IST			5-day change	1st Jan Change
30.68 ^USD	+0.52%		-0.42%	+1.56%

17/12	Corebridge Financial Joins S&P MidCap 400 Index	MT
17/12	Corebridge Financial, Inc.(NYSE:CRBG) added to S&P 1000	CI

Evolution of the Average Target: Corebridge Financial, Inc.

Evolution of the Target Price: Corebridge Financial, Inc.

Changes in Analyst Recommendations: Corebridge Financial, Inc.

a1b7dcf51b.aRx2XIfhjmo7sYmpDOujs6r4tzYmJ12DR4KZa460sDg.Ink0EOHUuCgJ7s79a9nL2sPV9m5JFA_tDsPhJsPE4HZZLDQItpfsLUvr3A~ba45bb3f4522507d52dcc7483a048f0c

Analysts' recommendations: Corebridge Financial, Inc.

08/01	UBS Adjusts Corebridge Financial Price Target to $33 From $35, Maintains Neutral Rating	MT
16/12	Mizuho Initiates Corebridge Financial at Outperform	MT
18/11	Corebridge Financial Shares Fall After Morgan Stanley Downgrade	MT
17/11	Morgan Stanley Downgrades Corebridge Financial to Equalweight From Overweight, Price Target is $39	MT
01/25/01	Corebridge Financial, Inc. Announces Resignation of Elias Habayeb as Chief Financial Officer, Effective April 24, 2026	CI
13/25/13	BofA Securities Adjusts PT on Corebridge Financial to $39 From $40, Maintains Buy Rating	MT
10/25/10	Wolfe Research Initiates Coverage on Corebridge Financial With Peer Perform Rating	MT
09/25/09	Analyst recommendations: Boston Scientific, Constellation Brands, Alliant Energy, Brixmor Property Group, Alcoa...
05/25/05	Corebridge reports Q2 net loss of $660 mln	RE
15/25/15	BofA Securities Adjusts Price Target on Corebridge Financial to $39 From $35, Maintains Buy Rating	MT
11/25/11	Corebridge Financial's Variable Annuity Deal Eliminates Fundamental Downside Risk, UBS Says	MT
11/25/11	UBS Upgrades Corebridge Financial to Neutral, Price Target is $37	MT
20/25/20	Analyst recommendations; Applovin, HP, Metlife, Micron, Pure Storage….
02/25/02	UBS Downgrades Corebridge Financial to Sell From Buy, Cuts Price Target to $28 From $40	MT
28/25/28	Deutsche Bank Trims Corebridge Financial Price Target to $39 From $40, Maintains Buy Rating	MT
28/25/28	Morgan Stanley Upgrades Corebridge Financial to Overweight From Equal Weight, $35 Price Target	MT
28/25/28	Analyst recommendations: MetLife, PayPal, Duolingo, Nvidia, Warner Bros Discovery…
14/25/14	RBC Lifts Price Target on Corebridge Financial to $36 From $35, Keeps Outperform Rating	MT
23/25/23	BMO Capital Initiates Corebridge Financial at Outperform With $43 Price Target	MT
10/25/10	Deutsche Bank Upgrades Corebridge Financial to Buy From Hold, Raises Price Target to $40 From $33	MT
06/25/06	Barclays Upgrades Corebridge Financial to Overweight From Equalweight, Price Target is $37	MT
11/24/11	UBS Adjusts Price Target on Corebridge Financial to $40 From $35, Maintains Buy Rating	MT
05/24/05	Morgan Stanley Adjusts Corebridge Financial's Price Target to $34 From $31, Keeps Equalweight Rating	MT
09/24/09	TD Cowen Initiates Corebridge Financial at Buy With $35 Price Target	MT
20/24/20	Deutsche Bank Raises Corebridge Financial Price Target to $33 From $24, Maintains Hold Rating	MT

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	COREBRIDGE FINANCIAL, INC.					+23.5%
	PING AN INSURANCE (GROUP) COMPANY OF CHINA, LTD.					+12.32%
	AXA					+15.61%
	MANULIFE FINANCIAL CORPORATION					+2.86%
	GENERALI					+1.8%
	CHINA PACIFIC INSURANCE (GROUP) CO., LTD.					-0.23%
	AFLAC INCORPORATED					+0.6%
	METLIFE, INC.					+16.89%
	GREAT-WEST LIFECO INC.					-2.17%
	PRUDENTIAL FINANCIAL, INC.					+1.58%
	Average					+7.28%
	Weighted average by Cap.					+7.71%

See all sector consensus

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

30.52USD

Average target price

37.69USD

Spread / Average Target

+23.50%

High Price Target

42.00USD

Spread / Highest target

+37.61%

Low Price Target

33.00USD

Spread / Lowest Target

+8.13%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

UBS
Mizuho Securities
Morgan Stanley
BofA Securities
Wolfe Research
Deutsche Bank Securities
RBC Capital Markets
BMO Capital
Barclays
TD Cowen
Wells Fargo Securities
Piper Sandler
Evercore ISI
Goldman Sachs
Jefferies & Co.
Citigroup
Autonomous Research
Oppenheimer
Credit Suisse
JPMorgan Chase
Keefe, Bruyette & Woods